clinical trial · NCT06791187
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
Boehringer Ingelheim·phase1·completed·n = 14
Healthydabigatran etexilateBI 1291583
brief summary
The main objective of this trial is to investigate the effect of a single dose of BI 1291583 on the pharmacokinetics of a single dose of dabigatran, an efflux transporter P-glycoprotein (P-gp) substrate.
started
Jan 23, 2025
primary completion
Feb 21, 2025
completion
Mar 27, 2025
last updated
Aug 13, 2025
official title
The Effect of a Single Dose of BI 1291583 on the Pharmacokinetics of a Single Dose of Dabigatran Following Oral Administration in Healthy Adult Male Subjects (an Open-label, 2- Period, Fixed-sequence Study)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol